Page last updated: 2024-11-12

sam-531

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

SAM-531: a 5-HT6 receptor antagonist; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID16071605
CHEMBL ID2103880
SCHEMBL ID3534330
SCHEMBL ID21381542
MeSH IDM0585942

Synonyms (38)

Synonym
pf-5212365
pf-05212365
cerlapirdine
way-262531
sam-531
925448-93-7
cerlapirdine (usan)
D10099
sam531
sam 531
ek40pj0v49 ,
cerlapirdine [usan:inn]
unii-ek40pj0v49
way-262,531
sam-531 free base
CHEMBL2103880
gtpl7356
n,n-dimethyl-3-[(3-naphthalen-1-ylsulfonyl-2h-indazol-5-yl)oxy]propan-1-amine
cerlapirdine [usan]
1-propanamine, n,n-dimethyl-3-((3-(1-naphthalenylsulfonyl)-1h-indazol-5-yl)oxy)-
cerlapirdine [inn]
cerlapirdine [who-dd]
n,n-dimethyl-3-((3-((naphthalen-1-yl)sulfonyl)-1h-indazol-5-yl)oxy)propan-1-amine
n,n-dimethyl-3-((3-(1-naphthylsulfonyl)-1h-indazol-5-yl)oxy)propan-1-amine
SCHEMBL3534330
NXQGEDVQXVTCDA-UHFFFAOYSA-N
dimethyl-{3-[3-(naphthalene-1-sulfonyl)-1h-indazol-5-yloxy]-propyl}-amine
DB12229
Q5064514
n,n-dimethyl-3-((3-(naphthalen-1-ylsulfonyl)-2h-indazol-5-yl)oxy)propan-1-amine
925448-93-7 (free base)
SCHEMBL21381542
HY-14431
N,N-DIMETHYL-3-((3-(NAPHTHALEN-1-YLSULFONYL)-1H-INDAZOL-5-YL)OXY)PROPAN-1-AMINE
DTXSID201137232
CS-0003354
F88545
AKOS040751077
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
5-hydroxytryptamine receptor 6Homo sapiens (human)Ki0.00130.00020.522910.0000AID1178357; AID1441516; AID1916468
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (6)

Processvia Protein(s)Taxonomy
cerebral cortex cell migration5-hydroxytryptamine receptor 6Homo sapiens (human)
positive regulation of TOR signaling5-hydroxytryptamine receptor 6Homo sapiens (human)
G protein-coupled serotonin receptor signaling pathway5-hydroxytryptamine receptor 6Homo sapiens (human)
chemical synaptic transmission5-hydroxytryptamine receptor 6Homo sapiens (human)
adenylate cyclase-modulating G protein-coupled receptor signaling pathway5-hydroxytryptamine receptor 6Homo sapiens (human)
G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger5-hydroxytryptamine receptor 6Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (4)

Processvia Protein(s)Taxonomy
histamine receptor activity5-hydroxytryptamine receptor 6Homo sapiens (human)
protein binding5-hydroxytryptamine receptor 6Homo sapiens (human)
neurotransmitter receptor activity5-hydroxytryptamine receptor 6Homo sapiens (human)
G protein-coupled serotonin receptor activity5-hydroxytryptamine receptor 6Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (4)

Processvia Protein(s)Taxonomy
plasma membrane5-hydroxytryptamine receptor 6Homo sapiens (human)
cilium5-hydroxytryptamine receptor 6Homo sapiens (human)
synapse5-hydroxytryptamine receptor 6Homo sapiens (human)
dendrite5-hydroxytryptamine receptor 6Homo sapiens (human)
plasma membrane5-hydroxytryptamine receptor 6Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID1916468Binding affinity to 5-HT6R (unknown origin) assessed as inhibition constant2021Bioorganic & medicinal chemistry letters, 10-01, Volume: 49Chemical update on the potential for serotonin 5-HT
AID1441516Antagonist activity at 5-HT6 receptor (unknown origin)2017Journal of medicinal chemistry, 03-09, Volume: 60, Issue:5
Discovery and Development of 1-[(2-Bromophenyl)sulfonyl]-5-methoxy-3-[(4-methyl-1-piperazinyl)methyl]-1H-indole Dimesylate Monohydrate (SUVN-502): A Novel, Potent, Selective and Orally Active Serotonin 6 (5-HT
AID1178357Antagonist activity at human recombinant 5HT6 receptor expressed in CHO cells2014Journal of medicinal chemistry, Sep-11, Volume: 57, Issue:17
Serotonin 5-HT6 receptor antagonists for the treatment of cognitive deficiency in Alzheimer's disease.
AID1441461Reversal of time-induced amnesia in Wistar rat at 1 to 3 mg/kg, sc administered 60 mins prior to testing measured for 3 mins by object recognition test2017Journal of medicinal chemistry, 03-09, Volume: 60, Issue:5
Discovery and Development of 1-[(2-Bromophenyl)sulfonyl]-5-methoxy-3-[(4-methyl-1-piperazinyl)methyl]-1H-indole Dimesylate Monohydrate (SUVN-502): A Novel, Potent, Selective and Orally Active Serotonin 6 (5-HT
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (80.00)24.3611
2020's1 (20.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 17.98

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index17.98 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.59 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (17.98)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (40.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other3 (60.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]